NCT02084095 IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly Status COMPLETED Phase N/A
NCT02060383 Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Status COMPLETED Phase PHASE4
NCT02020967 Programme of Acromegaly Screening in Patients With Associated Somatic Disorders Status COMPLETED Phase N/A
NCT02012127 Description of Sign-and-symptom Associations at Acromegaly Diagnosis. Status COMPLETED Phase N/A
NCT01995734 An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly Status APPROVED_FOR_MARKETING Phase N/A
NCT01902420 Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly Status UNKNOWN Phase N/A
NCT01861717 A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. Status TERMINATED Phase PHASE4
NCT01819883 Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly Status COMPLETED Phase N/A
NCT01794793 Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Status COMPLETED Phase PHASE4
NCT01723748 Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects Status COMPLETED Phase NA
NCT01673646 Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism Status COMPLETED Phase PHASE2
NCT01618513 Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target Status COMPLETED Phase PHASE4
NCT01568359 Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors Status COMPLETED Phase N/A